Bal Pharma Share Price
105.02-3.26 (-3.01%)
+24.48% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
BALPHARMANSE
Bal Pharma Share Price
105.02-3.26 (-3.01%)
+24.48% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| 5% | 4% | 1% | 3% |
| 16% | 6% | 35% | -13% |
| 1% | 0% | 5% | 28% |
| 3% | 9% | 10% | 8% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
BALPHARMA
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,849.9 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,602 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,928.5 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,180.3 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,399 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,026.2 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,500 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,200.4 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,716 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,100.7 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
| 103.81 | ₹172 Cr | 23.83 | 0.71 | 11.65 | ₹6 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Share Warrants & Outstandings
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Miscellaneous Expenses not written off
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 | Mar 2007 | Mar 2006 | Mar 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹16 Cr | ₹15 Cr | ₹15 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹14 Cr | ₹13 Cr | ₹13 Cr | ₹11 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹10 Cr | ₹7 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹94 L | ₹94 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹19 L | ₹19 L | ₹23 L | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹66 Cr | ₹61 Cr | ₹56 Cr | ₹48 Cr | ₹43 Cr | ₹38 Cr | ₹38 Cr | ₹52 Cr | ₹51 Cr | ₹48 Cr | ₹40 Cr | ₹40 Cr | ₹37 Cr | ₹26 Cr | ₹25 Cr | ₹27 Cr | ₹24 Cr | ₹23 Cr | ₹22 Cr | ₹12 Cr |
| ₹66 Cr | ₹61 Cr | ₹56 Cr | ₹48 Cr | ₹43 Cr | ₹38 Cr | ₹38 Cr | ₹52 Cr | ₹51 Cr | ₹48 Cr | ₹40 Cr | ₹40 Cr | ₹37 Cr | ₹26 Cr | ₹25 Cr | ₹27 Cr | ₹24 Cr | ₹23 Cr | ₹22 Cr | ₹12 Cr |
| ₹82 Cr | ₹77 Cr | ₹72 Cr | ₹64 Cr | ₹59 Cr | ₹54 Cr | ₹52 Cr | ₹67 Cr | ₹65 Cr | ₹62 Cr | ₹55 Cr | ₹55 Cr | ₹50 Cr | ₹36 Cr | ₹36 Cr | ₹37 Cr | ₹35 Cr | ₹33 Cr | ₹32 Cr | ₹20 Cr |
| ₹3 L | -₹1 L | -₹3 L | -₹9 L | -₹13 L | -₹23 L | -₹7 Cr | -₹6 Cr | -₹5 Cr | -₹2 Cr | -₹18 L | -₹3 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹26 Cr | ₹25 Cr | ₹23 Cr | ₹14 Cr | ₹27 Cr | ₹24 Cr | ₹23 Cr | ₹29 Cr | ₹33 Cr | ₹13 Cr | ₹15 Cr | ₹6 Cr | ₹7 Cr | ₹54 Cr | ₹54 Cr | ₹46 Cr | ₹42 Cr | ₹33 Cr | ₹35 Cr | ₹23 Cr |
| ₹6 Cr | ₹7 Cr | ₹13 Cr | ₹16 Cr | ₹0 | ₹0 | ₹22 L | ₹0 | ₹1 Cr | ₹5 Cr | ₹20 Cr | ₹53 L | ₹1 Cr | ₹4 Cr | ₹97,470 | ₹83 L | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹6 Cr |
| -₹80 L | -₹41 L | ₹2 Cr | ₹70 L | ₹60 L | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹8 Cr | ₹8 Cr | ₹7 Cr | ₹7 Cr | ₹8 Cr | ₹7 Cr | ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr |
| ₹6 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | ₹90 L | ₹75 L | ₹66 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹43 Cr | ₹38 Cr | ₹45 Cr | ₹38 Cr | ₹36 Cr | ₹34 Cr | ₹34 Cr | ₹38 Cr | ₹46 Cr | ₹30 Cr | ₹45 Cr | ₹16 Cr | ₹18 Cr | ₹65 Cr | ₹61 Cr | ₹53 Cr | ₹50 Cr | ₹40 Cr | ₹41 Cr | ₹33 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹89 Cr | ₹82 Cr | ₹77 Cr | ₹79 Cr | ₹66 Cr | ₹47 Cr | ₹39 Cr | ₹47 Cr | ₹50 Cr | ₹54 Cr | ₹47 Cr | ₹39 Cr | ₹34 Cr | ₹27 Cr | ₹22 Cr | ₹23 Cr | ₹17 Cr | ₹10 Cr | ₹12 Cr | ₹11 Cr |
| ₹46 Cr | ₹29 Cr | ₹27 Cr | ₹31 Cr | ₹24 Cr | ₹24 Cr | ₹31 Cr | ₹28 Cr | ₹34 Cr | ₹16 Cr | ₹12 Cr | ₹12 Cr | ₹9 Cr | ₹6 Cr | ₹5 Cr | ₹6 Cr | ₹4 Cr | ₹5 Cr | ₹1 Cr | ₹2 Cr |
| ₹113 Cr | ₹107 Cr | ₹96 Cr | ₹93 Cr | ₹71 Cr | ₹81 Cr | ₹90 Cr | ₹87 Cr | ₹68 Cr | ₹71 Cr | ₹50 Cr | ₹40 Cr | ₹43 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹78 L | ₹1 Cr | ₹3 Cr | ₹7 Cr | ₹5 Cr | ₹98 L | ₹50 L | ₹96 L | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹99 L | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
| ₹249 Cr | ₹220 Cr | ₹203 Cr | ₹209 Cr | ₹166 Cr | ₹153 Cr | ₹159 Cr | ₹163 Cr | ₹154 Cr | ₹143 Cr | ₹111 Cr | ₹92 Cr | ₹87 Cr | ₹35 Cr | ₹28 Cr | ₹31 Cr | ₹24 Cr | ₹17 Cr | ₹15 Cr | ₹14 Cr |
| ₹375 Cr | ₹335 Cr | ₹320 Cr | ₹311 Cr | ₹261 Cr | ₹240 Cr | ₹238 Cr | ₹261 Cr | ₹260 Cr | ₹233 Cr | ₹211 Cr | ₹164 Cr | ₹155 Cr | ₹135 Cr | ₹124 Cr | ₹122 Cr | ₹109 Cr | ₹90 Cr | ₹88 Cr | ₹67 Cr |
| ₹6 Cr | ₹17 Cr | ₹17 Cr | ₹16 Cr | ₹16 Cr | ₹13 Cr | ₹13 Cr | ₹20 Cr | ₹8 Cr | ₹12 Cr | ₹15 Cr | ₹18 Cr | ₹17 Cr | ₹12 Cr | ₹6 Cr | ₹9 Cr | ₹11 Cr | ₹13 Cr | ₹15 Cr | ₹4 Cr |
| ₹160 Cr | ₹150 Cr | ₹140 Cr | ₹131 Cr | ₹104 Cr | ₹110 Cr | ₹118 Cr | ₹124 Cr | ₹110 Cr | ₹93 Cr | ₹89 Cr | ₹49 Cr | ₹52 Cr | ₹58 Cr | ₹54 Cr | ₹47 Cr | ₹45 Cr | ₹35 Cr | ₹37 Cr | ₹29 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹175 Cr | ₹157 Cr | ₹140 Cr | ₹127 Cr | ₹111 Cr | ₹105 Cr | ₹98 Cr | ₹90 Cr | ₹85 Cr | ₹66 Cr | ₹106 Cr | ₹95 Cr | ₹90 Cr | ₹77 Cr | ₹74 Cr | ₹67 Cr | ₹37 Cr | ₹35 Cr | ₹27 Cr | ₹22 Cr |
| ₹81 Cr | ₹70 Cr | ₹61 Cr | ₹51 Cr | ₹44 Cr | ₹37 Cr | ₹27 Cr | ₹19 Cr | ₹13 Cr | ₹6 Cr | ₹50 Cr | ₹43 Cr | ₹35 Cr | ₹23 Cr | ₹19 Cr | ₹13 Cr | ₹11 Cr | ₹9 Cr | ₹7 Cr | ₹6 Cr |
| ₹94 Cr | ₹87 Cr | ₹80 Cr | ₹76 Cr | ₹67 Cr | ₹69 Cr | ₹71 Cr | ₹70 Cr | ₹71 Cr | ₹60 Cr | ₹56 Cr | ₹52 Cr | ₹55 Cr | ₹54 Cr | ₹55 Cr | ₹55 Cr | ₹27 Cr | ₹26 Cr | ₹20 Cr | ₹16 Cr |
| ₹7 Cr | ₹3 Cr | ₹47 L | ₹0 | ₹2 Cr | ₹0 | ₹3 Cr | ₹4 Cr | ₹21 L | ₹2 Cr | ₹4 Cr | ₹77 L | ₹25 L | ₹13 L | ₹0 | ₹40 L | ₹19 Cr | ₹7 Cr | ₹2 Cr | ₹3 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹12 L | ₹2 Cr | ₹12 L |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹2 L | ₹12 L | ₹2 Cr | ₹12 L |
| ₹6 Cr | ₹6 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹2 Cr | ₹3 Cr | ₹7 Cr | ₹8 Cr | ₹5 Cr | ₹4 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹5 Cr | ₹4 Cr | ₹45 L | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹55 L | ₹46 L | ₹32 L | ₹34 L | ₹24 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹113 Cr | ₹100 Cr | ₹86 Cr | ₹83 Cr | ₹76 Cr | ₹76 Cr | ₹81 Cr | ₹78 Cr | ₹75 Cr | ₹69 Cr | ₹68 Cr | ₹59 Cr | ₹60 Cr | ₹54 Cr | ₹55 Cr | ₹55 Cr | ₹46 Cr | ₹33 Cr | ₹25 Cr | ₹19 Cr |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ₹2 Cr | ₹2 Cr | ₹7 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹116 Cr | ₹103 Cr | ₹88 Cr | ₹98 Cr | ₹74 Cr | ₹60 Cr | ₹68 Cr | ₹70 Cr | ₹66 Cr | ₹55 Cr | ₹42 Cr | ₹36 Cr | ₹32 Cr | ₹32 Cr | ₹29 Cr | ₹24 Cr | ₹25 Cr | ₹24 Cr | ₹25 Cr | ₹23 Cr |
| ₹94 Cr | ₹92 Cr | ₹100 Cr | ₹94 Cr | ₹75 Cr | ₹67 Cr | ₹50 Cr | ₹65 Cr | ₹64 Cr | ₹62 Cr | ₹57 Cr | ₹45 Cr | ₹45 Cr | ₹37 Cr | ₹32 Cr | ₹29 Cr | ₹23 Cr | ₹22 Cr | ₹22 Cr | ₹14 Cr |
| ₹7 Cr | ₹8 Cr | ₹13 Cr | ₹8 Cr | ₹5 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹4 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹73 L | ₹86 L | ₹5 Cr | ₹40 L |
| ₹14 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr | ₹12 Cr | ₹5 Cr | ₹4 Cr | ₹70 L | ₹24 L | ₹86 L | ₹1 Cr | ₹1 Cr | ₹93 L | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹0 | ₹0 | ₹2 Cr | ₹1 Cr |
| ₹29 Cr | ₹23 Cr | ₹22 Cr | ₹25 Cr | ₹17 Cr | ₹28 Cr | ₹33 Cr | ₹44 Cr | ₹50 Cr | ₹42 Cr | ₹38 Cr | ₹17 Cr | ₹14 Cr | ₹6 Cr | ₹5 Cr | ₹4 Cr | ₹9 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr |
| ₹262 Cr | ₹235 Cr | ₹234 Cr | ₹228 Cr | ₹185 Cr | ₹164 Cr | ₹157 Cr | ₹183 Cr | ₹185 Cr | ₹165 Cr | ₹143 Cr | ₹105 Cr | ₹95 Cr | ₹81 Cr | ₹69 Cr | ₹61 Cr | ₹58 Cr | ₹53 Cr | ₹59 Cr | ₹43 Cr |
| ₹13 Cr | ₹15 Cr | ₹31 Cr | ₹19 Cr | ₹19 Cr | ₹12 Cr | -₹2 Cr | ₹20 Cr | ₹30 Cr | ₹21 Cr | ₹32 Cr | ₹13 Cr | ₹8 Cr | ₹46 Cr | ₹41 Cr | ₹30 Cr | ₹35 Cr | ₹36 Cr | ₹44 Cr | ₹30 Cr |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹5 Cr | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr |
| ₹375 Cr | ₹335 Cr | ₹320 Cr | ₹311 Cr | ₹261 Cr | ₹240 Cr | ₹238 Cr | ₹261 Cr | ₹260 Cr | ₹233 Cr | ₹211 Cr | ₹164 Cr | ₹155 Cr | ₹135 Cr | ₹124 Cr | ₹122 Cr | ₹109 Cr | ₹90 Cr | ₹88 Cr | ₹67 Cr |
| ₹52 | ₹49 | ₹46 | ₹41 | ₹39 | ₹36 | ₹37 | ₹47 | ₹46 | ₹44 | ₹41 | ₹41 | ₹43 | ₹34 | ₹34 | ₹31 | ₹29 | ₹28 | ₹27 | ₹22 |
| ₹52 | ₹49 | ₹46 | ₹41 | ₹39 | ₹36 | ₹37 | ₹47 | ₹46 | ₹44 | ₹41 | ₹41 | ₹43 | ₹34 | ₹34 | ₹31 | ₹29 | ₹28 | ₹27 | ₹18 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Effect of Foreign Exchange Fluctuations
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | Mar 2014 | Mar 2011 | Mar 2010 | Mar 2009 | Mar 2008 | Mar 2007 | Mar 2002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ₹6 Cr | ₹5 Cr | ₹9 Cr | ₹5 Cr | ₹9 Cr | ₹4 Cr | -₹14 Cr | -₹20 L | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr | ₹7 Cr | ₹1 Cr | -₹91 L | ₹4 Cr | ₹4 Cr | ₹3 Cr | ₹0 |
| ₹27 Cr | ₹25 Cr | ₹22 Cr | ₹22 Cr | ₹17 Cr | ₹21 Cr | ₹19 Cr | ₹17 Cr | ₹15 Cr | ₹15 Cr | ₹11 Cr | ₹12 Cr | ₹10 Cr | ₹9 Cr | ₹7 Cr | ₹7 Cr | ₹5 Cr | ₹5 Cr | ₹0 |
| -₹2 Cr | -₹7 Cr | -₹4 Cr | -₹28 Cr | ₹2 Cr | -₹3 Cr | ₹18 Cr | -₹7 Cr | -₹16 Cr | -₹10 Cr | -₹33 Cr | -₹59 L | -₹3 Cr | -₹6 Cr | -₹11 Cr | ₹3 Cr | ₹60 L | ₹21 L | ₹0 |
| ₹31 Cr | ₹22 Cr | ₹27 Cr | -₹1 Cr | ₹28 Cr | ₹22 Cr | ₹23 Cr | ₹10 Cr | ₹2 Cr | ₹8 Cr | -₹19 Cr | ₹16 Cr | ₹14 Cr | ₹4 Cr | -₹4 Cr | ₹14 Cr | ₹10 Cr | ₹8 Cr | ₹0 |
| ₹31 Cr | ₹20 Cr | ₹23 Cr | -₹2 Cr | ₹27 Cr | ₹22 Cr | ₹23 Cr | ₹8 Cr | ₹58 L | ₹6 Cr | -₹19 Cr | ₹15 Cr | ₹13 Cr | ₹5 Cr | -₹5 Cr | ₹13 Cr | ₹9 Cr | ₹8 Cr | ₹0 |
| -₹21 Cr | -₹15 Cr | -₹19 Cr | -₹22 Cr | -₹9 Cr | -₹6 Cr | -₹5 Cr | -₹8 Cr | -₹4 Cr | -₹8 Cr | -₹14 Cr | -₹5 Cr | -₹7 Cr | -₹2 Cr | ₹5 Cr | -₹11 Cr | -₹14 Cr | -₹8 Cr | ₹0 |
| -₹10 Cr | -₹8 Cr | -₹1 Cr | ₹24 Cr | -₹17 Cr | -₹17 Cr | -₹20 Cr | ₹1 L | ₹4 Cr | -₹6 Cr | ₹32 Cr | -₹7 Cr | -₹8 Cr | -₹2 Cr | ₹74 L | -₹3 Cr | ₹6 Cr | -₹4 Cr | ₹0 |
| ₹55 L | -₹2 Cr | ₹3 Cr | ₹37 L | ₹9 L | ₹17 L | -₹1 Cr | -₹27 L | ₹55 L | -₹8 Cr | -₹86 L | ₹2 Cr | -₹2 Cr | ₹62 L | ₹13 L | -₹1 Cr | ₹1 Cr | -₹5 Cr | ₹0 |
| ₹2 Cr | ₹4 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹86 L | ₹2 Cr | ₹3 Cr | ₹2 Cr | -₹18 Cr | ₹5 Cr | ₹3 Cr | ₹5 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹6 Cr | ₹0 |
| ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | -₹36,000 | -₹14 L | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| ₹2 Cr | ₹2 Cr | ₹4 Cr | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹86 L | ₹2 Cr | ₹3 Cr | -₹25 Cr | ₹5 Cr | ₹5 Cr | ₹3 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹0 |
Fundamental Ratios
Consolidated
Standalone
Bal Pharma Share Price
105.02-3.26 (-3.01%)
+24.48% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 3
Bearish signals: 3 out of 9 oscillators
RSI
59.46Buy
STOCH %K
49.27Neutral
MACD Level(12,26)
5.21Buy
Ultimate Oscillator
43.84Sell
Aroon Oscillator
22.00Sell
BOP
-0.21Sell
CCI
51.84Neutral
Williams %R
-50.73Neutral
Momentum
17.31Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 8
Bearish signals: 1 out of 9 moving averages
EMA 9
104.72Buy
SMA 9
105.57Sell
EMA 21
99.70Buy
SMA 21
97.32Buy
EMA 50
93.44Buy
SMA 50
91.71Buy
EMA 200
85.67Buy
SMA 200
79.97Buy
WMA 20
102.61Buy
Pivot
Pivot
Classic
Resistance 5
126.91
Resistance 4
122.43
Resistance 3
117.95
Resistance 2
113.47
Resistance 1
110.87
Pivot
108.99
Support 1
106.39
Support 2
104.51
Support 3
100.03
Support 4
95.55
Support 5
91.07
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Bal Pharma Share Price
105.02-3.26 (-3.01%)
+24.48% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| 50.86% | 50.86% | 50.86% | 50.86% | 50.86% | 50.86% |
| 0.15% | 0.14% | 0.14% | 0.23% | 0.15% | 0.14% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 48.99% | 49.00% | 49.00% | 48.91% | 48.99% | 49.00% |
Bulk & block deals
Name
Orion Stocks Ltd
Orion Stocks Ltd
Orion Stocks Ltd
Orion Stocks Ltd
Nk Securities Research Private Limited
Mudupulavemula Surendranadha Reddy
Parth Infin Brokers Pvt Ltd
Nk Securities Research Private Limited
Mudupulavemula Surendranadha Reddy
Parth Infin Brokers Pvt Ltd
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 21 Jul 2026 | Purchase | 1.08 Cr | ₹89.58 | 1.20 L | Bulk | 0.754185 | BSE |
| 21 Jul 2026 | Purchase | 14.64 L | ₹89.69 | 16.32 K | Bulk | 0.102538 | NSE |
| 21 Jul 2026 | Sell | 1.10 Cr | ₹89.70 | 1.23 L | Bulk | 0.769705 | NSE |
| 21 Jul 2026 | Sell | 7.28 L | ₹89.80 | 8.10 K | Bulk | 0.050902 | BSE |
| 04 Apr 2025 | Purchase | 1.60 Cr | ₹121.03 | 1.32 L | Bulk | 0.829243 | NSE |
| 04 Apr 2025 | Purchase | 1.49 Cr | ₹120.96 | 1.23 L | Bulk | 0.775157 | NSE |
| 04 Apr 2025 | Purchase | 1.39 Cr | ₹125.31 | 1.11 L | Bulk | 0.695959 | NSE |
| 04 Apr 2025 | Sell | 1.60 Cr | ₹121.17 | 1.32 L | Bulk | 0.829243 | NSE |
| 04 Apr 2025 | Sell | 1.50 Cr | ₹121.51 | 1.23 L | Bulk | 0.775157 | NSE |
| 04 Apr 2025 | Sell | 1.38 Cr | ₹124.36 | 1.11 L | Bulk | 0.695959 | NSE |
Insider trading & SAST
Client name
Shailesh Siroya
Micro Labs Limited (Revised)
Micro Labs Ltd
Micro Labs Limited
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13 Apr 2022 | Promoter | Acquisition | 4.82 | 17.63 | 0 | — | 7.50 L | 13 Apr 2022 | Pref. Allotment | 27,45,459 | SAST | 29(2) | — |
| 21 Dec 2021 | Promoter | Acquisition | 2.030036 | 10.87 | 2.80 Cr | ₹92.96 | 3.01 L | 27 Aug 2021 | Market Purchase | 16,11,736 | Insider Trading | — | Equity Shares |
| 24 Nov 2021 | Promoter | Acquisition | 2.7 | 13.57 | 0 | — | 4 L | 23 Nov 2021 | Market | 20,11,736 | SAST | 29(2) | — |
| 24 Nov 2021 | Promoter | Acquisition | 2.698618 | 13.57 | 3.70 Cr | ₹92.45 | 4 L | 23 Nov 2021 | Market Purchase | 20,11,736 | Insider Trading | — | Equity Shares |
Bal Pharma Share Price
105.02-3.26 (-3.01%)
+24.48% past 1 Year
Bal Pharma Limited is a leading Indian Pharmaceutical Company specializing in Prescription Drugs Branded Formulations APIs Generic & OTC products Intravenous Infusions and Bulk Drugs. It has a rich experience
Corporate Actions
Date
Type
Details
Company details
Bal Pharma Share Price
105.02-3.26 (-3.01%)
+24.48% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Bal Pharma Share Price
105.02-3.26 (-3.01%)
+24.48% past 1 Year
News
Bal Pharma reports Profit after tax of 1.20 Crores, in the September 2024 quarter
Equity
BALPHARMA
Bal Pharma informs about board meeting
Equity
BALPHARMA
Bal Pharma: Co Says Commence Setting Up Of Green Field Project For 40.00 Crores Rupees (Not 30.00 Crores Rupees); Project Is Expected To Be Completed In 36 Months || Initial Production Capacity Of 120 Tonne'S Of Api'S, Intermediates/Annum (Correction)
Equity
BALPHARMA
Bal Pharma: Co Says Commence Setting Up Of Green Field Project For 30.00 Crores Rupees; Project Is Expected To Be Completed In 36 Months || Initial Production Capacity Of 120 Tonne'S Of Api'S, Intermediates/Annum
Equity
BALPHARMA
Bal Pharma: Board Meeting On Sept 9 To Consider Expanding Co'S Manufacturing Presence To For Api
Equity
BALPHARMA
Bal Pharma informs about annual report
Equity
BALPHARMA
Bal Pharma - Quaterly Results
Equity
BALPHARMA
Bal Pharma reports Profit after tax of 1.75 Crores, in the June 2024 quarter
Equity
BALPHARMA
Bal Pharma - Quaterly Results
Equity
BALPHARMA
Bal Pharma - Quaterly Results
Equity
BALPHARMA
Bal Pharma reports Profit after tax of 6.22 Crores, in the March 2024 quarter
Equity
BALPHARMA
BAL Pharma informs about compliance certificate
Equity
BALPHARMA
Bal Pharma informs about non-applicability of large corporate
Equity
BALPHARMA
Bal Pharma informs about press release
Equity
BALPHARMA
Bal Pharma - Quaterly Results
Equity
BALPHARMA
Bal Pharma reports Profit after tax of 1.26 Crores, in the December 2023 quarter
Equity
BALPHARMA
Bal Pharma - Quaterly Results
Equity
BALPHARMA
Bal Pharma informs about closure of trading window
Equity
BALPHARMA
Bal Pharma informs about newspaper publication
Equity
BALPHARMA
Bal Pharma reports Profit after tax of 1.60 Crores, in the September 2023 quarter
Equity
BALPHARMA

